"This meeting has provided the Company with clarity around the FDA’s expectations on what is required to achieve regulatory approval. We expect a constructive and positive dialogue with the FDA to continue as we progress the BTM towards commercialisation."
Sounds positive...
Thoughts anyone?
Add to My Watchlist
What is My Watchlist?